Member Login
  1. Stocks
    2. /
  2. Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
    3. /

NASDAQ:RXRX (Recursion Pharmaceuticals, Inc.)

About RXRX

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Latest News

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Could this Nvidia-backed growth stock be a millionaire-maker at $10?

| Ben McPoland

This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a single day!

Read more »

Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

| Ben McPoland

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

2 growth stocks I’d buy for the artificial intelligence (AI) revolution in 2024

| Ben McPoland

Ben McPoland takes a look at two intriguing and yet under-the-radar growth stocks that could deliver huge long-term returns.

Read more »